Piramal Enterprises climbs 2.5% after subsidiary completes full acquisition of Convergence Chemicals

Piramal Pharma on October 28, 2020, had approved the acquisition of additional 3,43,04,900 equity shares of CCPL for an aggregate cash consideration of Rs65.10cr from Navin Fluorine International Limited.

from India Infoline News Service https://ift.tt/2PcihgT